☆ 4.6 Letter

Limited Significance of Antifactor H Antibodies in Patients with Membranous Nephropathy

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2021)

Related references

Note: Only part of the references are listed.
Article Medicine, General & Internal

Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy

F. C. Fervenza et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Add to Collection
Letter Medicine, General & Internal

More about Factor H Autoantibodies in Membranous Nephropathy

Elisabetta Valoti et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Add to Collection
Letter Medicine, General & Internal

Factor H Autoantibodies and Membranous Nephropathy

Claudia Seikrit et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Add to Collection
Article Urology & Nephrology

Primary Membranous Nephropathy

William G. Couser

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)

Add to Collection
Article Urology & Nephrology

Anti-Phospholipase A2 Receptor Antibody Titer Predicts Post-Rituximab Outcome of Membranous Nephropathy

Piero Ruggenenti et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)

Add to Collection
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.